已收盘 09-20 16:00:00 美东时间
+0.050
+0.70%
Morgan Stanley analyst Jeffrey Hung maintains enGene Holdings (NASDAQ:ENGN) with a Overweight and maintains $40 price target.
09-11 23:32
enGene Holdings (ENGN) has shared an update. Ronald H.W. Cooper has been appoin...
07-24 19:17
Ron Cooper succeeds Jason Hanson as Chief Executive Officer and Director Company also announces Dr. Raj Pruthi's promotion to Chief Medical Officer
07-24 18:35
enGene Holdings (ENGN) has shared an update. On June 14, 2024, the Company rele...
06-14 19:58
enGene Holdings press release (NASDAQ:ENGN): Q2 GAAP EPS of -$0.38. Cash and cash equivalents, as of April 30, 2024, were $264.8 million. The Company expects that its existing cash and cash equivalent...
06-14 19:31
enGene Holdings (ENGN) has provided an announcement. enGene Holdings Inc. succe...
05-16 04:23
The company closed a $200 million oversubscribed private financing, expected to extend cash runway into 2027.
03-12 05:41
BOSTON and MONTREAL, March 5, 2024 /PRNewswire/ - enGene Holdings Inc. (Nasdaq: ENGN) or "enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral lead program E...
03-05 20:00
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to 15,765.18. The S&P 500 also rose, gaining, 0.49% to 4,977.43.
02-15 03:32
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 50 points on Wednesday. The Dow traded down 0.20% to 38,194.62 while the NASDAQ rose 0.19% to 15,686.43. The S&P 500 also rose, gaining, 0.11% to 4,958.84.
02-15 01:08